Life Science Nation Newsletter | April 18, 2019 | Issue 313


  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Consulting
   Life Science Investor Mandates
(Apr. 11 - Apr. 17 )
Invests Early in Therapeutics, Devices and Diagnostics
Leads Deals Across the Life Science Spectrum
Backs Startups to Improve Orthopedic Care
Invests in Early Stage Deals, Supports Clinical Trials
LSN Services
LSN Videos
LSN Media Partners
By Karen Deyo, Investor Research Analyst, LSN

LSN is gearing up for our next RESI on June 3 rd in Philadelphia. The conference will feature two RESI panel tracks, with panels designed to provide fundraising CEOs with advice on what investors and strategic partners are seeking, as well as tips on how to approach them. Panels will range from discussions by different types of investors, such as Corporate Venture Capital, Angels & Family Offices and Asia Corporates & Strategics, to those focused on particular areas, ranging from general topics such as Medical Device Investors and Early Stage Therapeutics to AI in Healthcare and Mental & Behavioral Health. Join us at RESI Philadelphia to hear the speakers below share their expertise.
  • Zishan Haroon, Julz Co., Aisa Therapeutics
  • Somjeet Dey, Otsuka Pharmaceuticals, Asia Therapeutics
  • Sohaib Siddiqui, Kettlebeck Developments, Digital Health
  • Richard Gordon, Inova Strategic Investments, Digital Health
  • Ronald Dorenbos, Takeda Pharmaceuticals - Materials & Innovation, Medical Device Investors
By Lucy Parkinson, VP of Investor Research, LSN

At the inaugural RESI Europe event, a panel of four investors discussed their focus on Investing in Oncology Innovation. It's well know that oncology is a hot area of investment; however with such a wealth of innovation to choose from, investors and startups both face many challenges in finding success. LSN would like to thank these investors for sharing their advice with RESI's audience, and we've made a short video to provide some of that wisdom to the rest of the world. 

The participants were:
  • Claus Andersson (Moderator) - Sunstone Life Science Ventures
  • Katherine Cohen - Panacea Ventures
  • Mark Krul - Aglaia Oncology Funds
  • Toshiyashu Shimomura - Taiho Ventures
The field of oncology research is advancing rapidly, partly due to new research tools such as tumor sequencing; immuno-oncology, in particular, represents many of the leading approaches in the cancer field...


By Jessica Yang, Investor Research Analyst, LSN

The day before RESI Philadelphia, the 2019 Taiwan Biotech Forum will be held at Temple University Science Education and Research Center on June 2nd, 2019.

Hosted by the Development Center of Biotechnology (DCB), the forum aims to bring innovative emerging biotechnologies in Taiwan to the audience. Topics include Biologics and AI for biomedical product development, regenerative medicine, and microbiome. Keynote speeches and panels will discuss these topics from the prospective of investment and innovation. Additionally, innovative companies from Taiwan will pitch their novel technologies to the audience. ..

Get 15% off the public price with code: LSN15

Created & Produced by